<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="86462">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01979575</url>
  </required_header>
  <id_info>
    <org_study_id>495567</org_study_id>
    <nct_id>NCT01979575</nct_id>
  </id_info>
  <brief_title>Trendelenburg Study</brief_title>
  <official_title>An Observational Study on the Effects of Steep Trendelenburg Position and Pneumoperitoneum on Hemodynamic Changes Observed With Non-invasive Cardiac Monitors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1) Observe the hemodynamic and cardiovascular changes associated with the change from the
      supine to the steep Trendelenburg position, 2) Observe the hemodynamic and cardiovascular
      changes during intra-abdominal insufflation used during laparoscopic surgical procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single site, prospective, non-blinded, non-randomized, non-interventional study
      designed to evaluate the hemodynamic and cardiovascular effects of the steep Trendelenburg
      position on non-invasive or minimally invasive monitors used in the operating room during
      surgical procedures requiring this patient position.

      SPECIFIC AIMS: 1) Observe the hemodynamic and cardiovascular changes associated with the
      change from the supine to the steep Trendelenburg position. 2) Observe the hemodynamic and
      cardiovascular changes during intra-abdominal insufflation used during laparoscopic surgical
      procedures.

      HYPOTHESIS: Hemodynamic and cardiovascular changes during alterations in position from
      supine to steep Trendelenburg and intra-abdominal insufflation measured by non-invasive and
      minimally invasive monitors will correlate with transthoracic echocardiographic
      measurements.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>An observational study on the effects of steep Trendelenburg position and pneumoperitoneum on hemodynamic changes observed with non-invasive cardiac monitors</measure>
    <time_frame>One year.</time_frame>
    <description>Changes in cardiac output associated with patient position.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Comparison of Non-invasive Monitors of Cardiac Function</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for elective surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for elective surgery requiring steep trendelenburg positioning.

        Exclusion Criteria:

          -  BMI &gt;30. &lt;18 years. Pregnancy. Prisoners.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UC Davis Health System</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 16, 2017</lastchanged_date>
  <firstreceived_date>November 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Davis</investigator_affiliation>
    <investigator_full_name>Neal Fleming, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Nexfin</keyword>
  <keyword>Flotrac</keyword>
  <keyword>Esophageal</keyword>
  <keyword>Cardiac output</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
